文献速递眼底病与葡萄膜炎

急性视网膜坏死的诊断与治疗:美国眼科学会报告

Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.
PubMed 文献 · Ophthalmology · 2017-01-13

该报告由美国眼科学会基于截至2016年7月27日的文献检索,评估急性视网膜坏死(ARN)诊断与治疗的证据。房水或玻璃体PCR检测HSV或VZV在疑似ARN病例中阳性率为79%至100%,房水和玻璃体标本均敏感且特异。有II级和III级证据支持静脉或口服抗病毒治疗,口服伐昔洛韦与静脉阿昔洛韦可达到等效血浆药物水平;玻璃体腔膦甲酸钠联合全身抗病毒治疗可能比单用全身治疗更有效;预防性激光或早期玻璃体切割术预防视网膜脱离的效果尚不明确。

要点

  • 房水或玻璃体PCR检测HSV或VZV在疑似ARN病例中阳性率为79%至100%,但治疗不应等待PCR结果。
  • 有II级和III级证据支持静脉或口服抗病毒药物治疗ARN,口服伐昔洛韦与静脉阿昔洛韦可达等效血浆药物水平。
  • 有II级和III级证据提示玻璃体腔膦甲酸钠联合全身抗病毒治疗可能比单用全身治疗更有效;预防性激光或早期PPV的作用尚不明确。

核心结论

  • 眼液PCR检测有助于支持ARN的临床诊断,但治疗不应等待PCR结果而延迟。
  • 初始口服或静脉抗病毒治疗对ARN有效。
  • 辅助使用玻璃体腔膦甲酸钠可能比单用全身治疗更有效。
  • 预防性激光视网膜固定术或早期PPV的作用目前尚不明确。

研究设计与样本

  • 文献检索PubMed和Cochrane Library数据库,最后检索日期为2016年7月27日。
  • 检索识别216条独特引用,49篇可能具有临床相关性的文章进行全文审查,其中27篇被认为足够相关或感兴趣并按证据强度评级。
  • 从这些文章的参考文献列表中额外识别6篇文章并纳入,共33项研究均为回顾性研究。

主要发现

  • 房水或玻璃体PCR检测HSV或VZV在疑似ARN病例中阳性率为79%至100%。
  • 房水和玻璃体标本均敏感且特异。
  • 有II级和III级证据支持使用静脉和口服抗病毒治疗ARN。
  • 数据提示口服伐昔洛韦或静脉阿昔洛韦给药后可达到等效的血浆阿昔洛韦药物水平。
  • 有II级和III级证据提示玻璃体腔膦甲酸钠联合全身抗病毒治疗可能比单用全身治疗具有更大疗效。

关键数值与推荐

  • 房水或玻璃体PCR检测HSV或VZV在疑似ARN病例中阳性率为79%至100%。
  • 有II级和III级证据支持静脉和口服抗病毒治疗用于ARN。
  • 有II级和III级证据提示玻璃体腔膦甲酸钠联合全身抗病毒治疗可能比单用全身治疗更有效。

临床怎么用

  • 眼液PCR检测可用于支持ARN的临床诊断,但治疗不应等待PCR结果而延迟。
  • 初始口服或静脉抗病毒治疗对ARN有效。
  • 辅助使用玻璃体腔膦甲酸钠可能比单用全身治疗更有效。
  • 预防性激光视网膜固定术或早期PPV的作用目前尚不明确。

局限性

  • 所有33项研究均为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the available evidence in peer-reviewed publications about the diagnosis and treatment of acute retinal necrosis (ARN). METHODS: Literature searches of the PubMed and Cochrane Library databases were last conducted on July 27, 2016. The searches identified 216 unique citations, and 49 articles of possible clinical relevance were reviewed in full text. Of these 49 articles, 27 were deemed sufficiently relevant or of interest, and they were rated according to strength of evidence. An additional 6 articles were identified from the reference lists of these articles and included. All 33 studies were retrospective. RESULTS: Polymerase chain reaction (PCR) testing of aqueous or vitreous humor was positive for herpes simplex virus (HSV) or varicella zoster virus (VZV) in 79% to 100% of cases of suspected ARN. Aqueous and vitreous specimens are both sensitive and specific. There is level II and III evidence supporting the use of intravenous and oral antiviral therapy for the treatment of ARN. Data suggest that equivalent plasma drug levels of acyclovir can be achieved after administration of oral valacyclovir or intravenous acyclovir. There is level II and III evidence suggesting that the combination of intravitreal foscarnet and systemic antiviral therapy may have greater therapeutic efficacy than systemic therapy alone. The effectiveness of prophylactic laser or early pars plana vitrectomy (PPV) in preventing retinal detachment (RD) remains unclear. CONCLUSIONS: Polymerase chain reaction testing of ocular fluid is useful in supporting a clinical diagnosis of ARN, but treatment should not be delayed while awaiting PCR results. Initial oral or intravenous antiviral therapy is effective in treating ARN. The adjunctive use of intravitreal foscarnet may be more effective than systemic therapy alone. The role of prophylactic laser retinopexy or early PPV is unknown at this time.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Schoenberger SD, Kim SJ, Thorne JE, et al. Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017. PMID: 28094044. doi:10.1016/j.ophtha.2016.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。